This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product IBRANCE 125 MG TABLET 7S. The contract, valued at $23,380.46, was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation.
The contract is a delivery order type with a firm fixed-price pricing structure. It was awarded on September 16, 2024 and has an ultimate completion date of October 7, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, will be delivering the specified drug to support the DLA's medical programs and facilities.
This contract award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The company also has an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for providing medical products and prescription drugs.
Generated 12/16/24, 2:03 PM